Inflammation and Myocardial Blood Flow in Cardiac Sarcoidosis.

Date publication

mai 2024

Journal

Current cardiology reports

Auteurs

Membres identifiés du Cancéropôle Est :
Pr IMPERIALE Alessio

Tous les auteurs :
Parihar AS, Valenta I, Mikhail S, Imperiale A, Schindler TH

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38775909

Résumé

Cardiac involvement in systemic sarcoidosis or isolated cardiac sarcoidosis plays a pivotal role in the clinical manifestation and prognostication. Active-inflammatory cardiac sarcoidosis is associated with a regional impairment of coronary microvascular function that may confer further detrimental effects on myocardial function needing further characterization.

Mots clés

18F-fluorodeoxyglucose, Cardiac involvement, Inflammation myocardial blood flow, Myocardial flow reserve, Positron emission tomography, Prognosis, Sarcoidosis

Référence

Curr Cardiol Rep. 2024 05 22;: